Founded in 1992, Crimson is the only translation practice devoted exclusively to Class II and III devices and List A and B IVDs. Crimson is the first translation practice in the world certified to ISO 9001:2008, ISO 13485:2003 and registered to ISO 14971:2009. Crimson has received official Notified Body recognition for its innovative application of the SAE J2450 translation quality standard. The company's specialized approach to translation risk management is the basis of the industry's only risk management patent (pending).

Crimson's specialized approach to medical technology translation has been featured in industry publications such as Medical Device & Diagnostics Industry, BI&T Journal (AAMI publication), Orthopedic Design & Technology, and Medical Products Outsourcing.

In 2005, Crimson joined the growing TransPerfect family of companies. Clients benefit from Crimson's audited quality and risk management systems, combined with the extensive technology resources and localization talent of TransPerfect and its software localization unit, Translations.com.